Back

Quantification of late-gadolinium enhancement magnetic resonance imaging to predict ventricular arrythmias and sudden cardiac death: A systematic review

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Noninvasive diagnostic methods Noninvasive Diagnostic Methods EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Thomas Nia Jensen

Aarhus University Hospital, Aarhus (Denmark)

5 More presentations in this session

Presentation thumbnail
The influence of delayed ventricular activation on cardiac repolarization: insights from electrocardiographic imaging
Ms K. Smits (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
24 h holter monitoring in myotonic dystrophy type 1 follow-up: is it really needed?
Doctor A. Fernandes (Braga, PT)
Abstract Slides Video
Presentation thumbnail
Imageless electrocardiographic imaging for the location of premature ventricular contractions
Miss L. Gonzalez Ruiz (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Early arrhythmia risk stratification: echocardiographic strain insights for non-invasive prediction of atrial conduction abnormalities
Miss M. Linderhof (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Validation of imageless electrocardiographic imaging for accessory pathway localisation in WPW syndrome
Ms S. Monteiro (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Noninvasive diagnostic methods

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Late gadolinium enhancement and ventricular arrhythmias in patients with dilated cardiomyopathy: a systematic review and meta-analysis
thumbnail
Congress Presentation
Evaluating the predictive value of late gadolinium enhancement for major ventricular arrhythmia in phospholamban p.(Arg14del)-positive individuals.
thumbnail
Congress Presentation
Quantifying late gadolinium enhancement improved sudden cardiac death risk prediction in non-ischemic dilated cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources